Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel E Furst

Showing results (81-90 of 477) with videos related to

Pageof 48
Sort By:
The Journal of Rheumatology|October 3, 2013
We still don't know how to taper glucocorticoids in rheumatoid arthritis, and we can do betterElizabeth R Volkmann, Shadi Rezai, Simon Tarp, et al.
Nature Reviews. Nephrology|January 3, 2018
Scleroderma renal crisis and renal involvement in systemic sclerosisThasia G Woodworth, Yossra A Suliman, Wendi Li, et al.
Rheumatology and Therapy|March 5, 2018
A Review of Recent Advances Using Tocilizumab in the Treatment of Rheumatic DiseasesAndrea Rubbert-Roth, Daniel E Furst, Jan Michael Nebesky, et al.
The Journal of Rheumatology|October 3, 2012
Annual medical costs and healthcare resource use in patients with systemic sclerosis in an insured populationDaniel E Furst, Ancilla W Fernandes, Serban R Iorga, et al.
Seminars in Arthritis and Rheumatism|March 7, 2021
Ultrasonographic imaging of systemic sclerosis digital ulcers: A systematic literature review and validation stepsYossra A Suliman, Cosimo Bruni, Michael Hughes, et al.
Current Rheumatology Reports|March 20, 2009
Current concepts in disease-modifying therapy for systemic sclerosis-associated interstitial lung disease: lessons from clinical trialsKaren Au, Dinesh Khanna, Philip J Clements, et al.
Clinical and Experimental Rheumatology|September 5, 2015
What tests should you use to assess small intestinal bacterial overgrowth in systemic sclerosis?Yolanda Braun-Moscovici, Marius Braun, Dinesh Khanna, et al.
Journal of Scleroderma and Related Disorders|March 2, 2018
Systemic Sclerosis Trial Design Moving ForwardSindhu R Johnson, Dinesh Khanna, Yannick Allanore, et al.
Rheumatology (Oxford, England)|October 10, 2017
Points to consider in renal involvement in systemic sclerosisFelice Galluccio, Ulf Müller-Ladner, Daniel E Furst, et al.
International Journal of Rheumatology|October 12, 2010
An International, Web-Based, Prospective Cohort Study to Determine Whether the Use of ACE Inhibitors prior to the Onset of Scleroderma Renal Crisis Is Associated with Worse Outcomes-Methodology and Preliminary ResultsMarie Hudson, Murray Baron, Ernest Lo, et al.
Pageof 48

Showing results (81-90 of 477) with videos related to

Sort By:
Pageof 48
The Journal of Rheumatology|October 3, 2013
We still don't know how to taper glucocorticoids in rheumatoid arthritis, and we can do betterElizabeth R Volkmann, Shadi Rezai, Simon Tarp, et al.
Nature Reviews. Nephrology|January 3, 2018
Scleroderma renal crisis and renal involvement in systemic sclerosisThasia G Woodworth, Yossra A Suliman, Wendi Li, et al.
Rheumatology and Therapy|March 5, 2018
A Review of Recent Advances Using Tocilizumab in the Treatment of Rheumatic DiseasesAndrea Rubbert-Roth, Daniel E Furst, Jan Michael Nebesky, et al.
The Journal of Rheumatology|October 3, 2012
Annual medical costs and healthcare resource use in patients with systemic sclerosis in an insured populationDaniel E Furst, Ancilla W Fernandes, Serban R Iorga, et al.
Seminars in Arthritis and Rheumatism|March 7, 2021
Ultrasonographic imaging of systemic sclerosis digital ulcers: A systematic literature review and validation stepsYossra A Suliman, Cosimo Bruni, Michael Hughes, et al.
Current Rheumatology Reports|March 20, 2009
Current concepts in disease-modifying therapy for systemic sclerosis-associated interstitial lung disease: lessons from clinical trialsKaren Au, Dinesh Khanna, Philip J Clements, et al.
Clinical and Experimental Rheumatology|September 5, 2015
What tests should you use to assess small intestinal bacterial overgrowth in systemic sclerosis?Yolanda Braun-Moscovici, Marius Braun, Dinesh Khanna, et al.
Journal of Scleroderma and Related Disorders|March 2, 2018
Systemic Sclerosis Trial Design Moving ForwardSindhu R Johnson, Dinesh Khanna, Yannick Allanore, et al.
Rheumatology (Oxford, England)|October 10, 2017
Points to consider in renal involvement in systemic sclerosisFelice Galluccio, Ulf Müller-Ladner, Daniel E Furst, et al.
International Journal of Rheumatology|October 12, 2010
An International, Web-Based, Prospective Cohort Study to Determine Whether the Use of ACE Inhibitors prior to the Onset of Scleroderma Renal Crisis Is Associated with Worse Outcomes-Methodology and Preliminary ResultsMarie Hudson, Murray Baron, Ernest Lo, et al.
Pageof 48